BCO1: A Drug Target / Disease Biomarker (G53630)

Target Name: BCO1

NCBI ID: G53630

BCO1

BCO1: A Drug Target / Disease Biomarker

BCO1, short for Bcl-2-associated death protein 1, is a protein that is expressed in various tissues throughout the body. It is a member of the Bcl-2 family of proteins, which are known for their ability to regulate cell death. BCO1 is primarily expressed in the brain, but is also found in other tissues such as the lungs, heart, and gastrointestinal tract.

The Bcl-2 family of proteins were identified as potential drug targets for cancer because of their ability to prevent cell death. Bcl-2 proteins have been shown to promote the survival of cancer cells, which may contribute to their development and progression.

BCO1 is a 21-kDa protein that is expressed in various tissues throughout the body. It is a member of the Bcl-2 family of proteins, which are known for their ability to regulate cell death. BCO1 is primarily expressed in the brain, but is also found in other tissues such as the lungs, heart, and gastrointestinal tract.

In addition to its expression in the brain, BCO1 is also expressed in other tissues throughout the body. This makes it a potential biomarker for a variety of diseases, including cancer.

One of the reasons why BCO1 is considered a drug target is its role in cell death. BCO1 is a member of the Bcl-2 family of proteins, which are known for their ability to prevent cell death. Bcl-2 proteins have been shown to promote the survival of cancer cells, which may contribute to their development and progression.

In addition to its role in cell death, BCO1 is also a potent inhibitor of apoptosis, which is a natural form of cell death. This means that BCO1 may be an effective target for drugs that are designed to induce or enhance apoptosis.

Another reason why BCO1 is considered a drug target is its expression in various tissues throughout the body. This makes it a potential biomarker for a variety of diseases, including cancer.

For example, BCO1 is often expressed in breast cancer tissue, which makes it a potential target for drugs that are designed to inhibit its activity. This may be an effective way to treat breast cancer, which is a leading cause of cancer-related deaths.

In addition to its potential as a drug target, BCO1 is also a promising biomarker for a variety of other diseases. For example, it has been shown to be expressed in the brains of individuals with Alzheimer's disease, which may be an effective way to diagnose or treat this debilitating disease.

In conclusion, BCO1 is a protein that is associated with cell death and has been shown to promote the survival of cancer cells. As a result, it is a potential drug target for a variety of diseases, including cancer. Its expression in various tissues throughout the body also makes it a promising biomarker for a variety of diseases. Further research is needed to fully understand the role of BCO1 as a drug target and its potential as a biomarker.

Protein Name: Beta-carotene Oxygenase 1

Functions: Symmetrically cleaves beta-carotene into two molecules of retinal using a dioxygenase mechanism

The "BCO1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BCO1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets